TGA Approval

Lotemax loteprednol etabonate 0.5% eye drop suspension (202525)

ARTG ID

202525

ARTG Name

Lotemax loteprednol etabonate 0.5% eye drop suspension

Sponsor

Bausch & Lomb Australia Pty Ltd

ARTG Date

January 16, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Bausch & Lomb (Australia) Pty Ltd.

Ingredient Name

loteprednol etabonate

Empowering clinical research with data-driven insights and AI-powered tools.

Lotemax loteprednol etabonate 0.5% eye drop suspension (202525) - TGA 批准文号 | MedPath